Navigation Links
Sandia completes depleted uranium study

Sandia National Laboratories has completed a two-year study of the potential health effects associated with accidental exposure to depleted uranium (DU) during the 1991 Gulf War.

The study, "An Analysis of Uranium Dispersal and Health Effects Using a Gulf War Case Study," performed by Sandia scientist Al Marshall, employs analytical capabilities used by Sandia's National Security Studies Department and examines health risks associated with uranium handling.

U.S. and British forces used DU in armor-piercing penetrator bullets to disable enemy tanks during the Gulf and Balkan wars. DU is a byproduct of the process used to enrich uranium for use in nuclear reactors and nuclear weapons. During the enrichment process, the fraction of one type of uranium (uranium-235) is increased relative to the fraction found in natural uranium. As a consequence, the uranium left over after the enrichment process (mostly uranium-238) is depleted in uranium-235 and is called depleted uranium.

The high density, low cost, and other properties of DU make it an attractive choice as an anti-tank weapon. However, on impact, DU particulate is dispersed in the surrounding air both within and outside the targeted vehicle and suspended particulate may be inhaled or ingested. Concerns have been raised that exposure to uranium particulate could have serious health problems including leukemia, cancers, and neurocognitive effects, as well as birth defects in the progeny of exposed veterans and civilians.

Marshall's study concluded that the reports of serious health risks from DU exposure are not supported by veteran medical statistics nor supported by his analysis. Only a few U.S. veterans in vehicles accidentally struck by DU munitions are predicted to have inhaled sufficient quantities of DU particulate to incur any significant health risk. For these individuals, DU-related risks include the possibility of temporary kidney damage and about a 1 percent chance of fatal c ancer.

Several earlier studies were carried out by the U.S. Department of Defense, by University Professors Fetter (University of Maryland) and von Hippel (Princeton), and by an Army sponsored team from Pacific Northwest National Laboratories and Los Alamos National Laboratory.

The conclusions from the Sandia study are consistent with these earlier studies. The Sandia study, however, also includes an analysis of potential health effects of DU fragments embedded as shrapnel in the bodies of some U.S. veterans. The Sandia study also looked at civilian exposures in greater detail, examined the potential risk of DU-induced birth defects in the children of exposed individuals, and provided a more detailed analysis of the dispersion of DU following impact with a number of targeted vehicles.


For a full copy of the report, download the following pdf file from : "An Analysis of Uranium Dispersal and Health Effects Using a Gulf War Case Study"


Source:DOE/Sandia National Laboratories

Related biology news :

1. Sandia work launched on space shuttle shows live cells influence growth of nanostructures
2. Sandia research to focus on early detection of harmful algal blooms
3. Sandia researchers discover way to see how a drug attaches to a cell
4. Sandia researchers take new approach to studying how cells respond to pathogens
5. Worlds largest rainforest drying experiment completes first phase
6. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
7. LIAI completes worlds most comprehensive analysis on influenza virus data
8. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
9. Canadian youth 4th highest in international obesity study
10. Frog peptides block HIV in lab study
11. Experimental shingles vaccine proves effective in nationwide study
Post Your Comments:

(Date:11/17/2015)... 2015 Paris from 17 ... Paris from 17 th until 19 ... innovation leader, has invented the first combined scanner in the ... same scanning surface. Until now two different scanners were required: one ... capture both on the same surface. This innovation is ...
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced expansion of its TDDI ... touch controller and display driver integration (TDDI) ... smartphones. These new TDDI products add to the ... resolution), TD4302 (WQHD resolution), and TD4322 (FHD resolution) ...
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , an ... of clinical research, is pleased to announce that it will ... Trials (PCT) event, to be held November 17-19 in ... to view live demonstrations of iMedNet , ... how iMedNet has been able to deliver time ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... November 24, 2015 SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Officer, will participate in the Piper Jaffray 27 th Annual ... on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. ...
(Date:11/24/2015)... 2015  Twist Bioscience, a company focused on ... Twist Bioscience chief executive officer, will present at ... 1, 2015 at 3:10 p.m. Eastern Time at The Lotte ... --> --> About ... is on Twitter. Sign up to follow our ...
(Date:11/24/2015)... 24, 2015 /CNW Telbec/ - ProMetic Life Sciences Inc. (TSX: ... Mr. Pierre Laurin , President and Chief Executive Officer ... upcoming Piper Jaffray 27 th Annual Healthcare Conference to ... 1-2, 2015. st , at 8.50am (ET) ... throughout the day. The presentation will be available live via ...
(Date:11/24/2015)... , November 24, 2015 , ... in a European healthcare ... the companies will work closely together in identifying European breakthrough ... medical need. The collaboration is underpinned by a significant investment ... This is the first investment by Bristol-Myers Squibb in a ...
Breaking Biology Technology: